CDK9 inhibitor Drug Pipeline Research Report 2024
GlobeNewswire
Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "CDK9 inhibitor - Pipeline Insight, 2024" drug pipelines has been added to *..
Myc
News and Video Search Results
News coverage
-
Nurix Therapeutics Reports First Clinical Evidence of CNS Activity of NX-5948, a Brain-Penetrant, Orally Available, BTK Degrader in Development for B Cell Malignancies
GlobeNewswire
-
Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual Meeting
PR Newswire Asia
-
Ribometrix Presents First c-MYC Data Validating RNA-Targeting Platform and Demonstrates Synergistic Potential of eIF4E Program at AACR 2024
Business Wire
-
Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire
0 shares
1 views
You might like
Myc media coverage
Jacobio Pharma Announces 2023 Annual Results
PR Newswire Asia
BEIJING, SHANGHAI and BOSTON, March 29, 2024 Jacobio/PRNewswire/ -- Pharma (1167.HK), a clinical-stage oncology company drugging..
-
Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
GlobeNewswire
-
GenFleet and BeiGene Enter into Trial Collaboration for a Potentially First-in-class Combination Therapy to Initiate Phase Ib/II Study of GFH009 (CDK9 inhibitor) and BRUKINSA® (zanubrutinib) Treating Diffuse Large B Cell Lymphoma
PR Newswire Asia
-
PI3K Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 75+ Companies Working in the Domain
GlobeNewswire
-
Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial Results
GlobeNewswire
Advertisement
More coverage
Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire
MRT-2359, a molecular glue degrader (MGD) being developed for MYC-driven solid tumors, advancing in ongoing Phase 1/2 clinical..
-
Study of Kintor's c-Myc Degrader Published in Subsidiary Journal of Nature
PR Newswire Asia
-
High School Seniors Win $1.8 Million at Regeneron Science Talent Search 2024 for Innovative Scientific Research on Artificial Intelligence, Cancer Metabolism and Mathematical Optimization
GlobeNewswire
-
Ribometrix to Present New Preclinical Data From RNA-Modulating Small Molecule Programs Targeting eIF4E and c-MYC at the 2024 AACR Annual Meeting
Business Wire
-
Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash Runway
GlobeNewswire